Department of Surgery
Kiran Turaga is a surgical oncologist with a special interest in the treatment of advanced malignancies, including metastatic cancers. He is an expert in regional perfusion, including hyperthermic intraperitoneal chemotherapy, a technique that delivers high doses of heated chemotherapy directly to abdominal organs to kill cancer cells that may remain after the surgical removal of visible tumors. He treats a wide range of abdominal and peritoneal diseases, including colon and appendix cancer, mesothelioma, and malignant bowel obstructions. He also has significant experience in the management of melanoma and complex sarcomas.
Turaga has published over 100 peer-reviewed articles and is an international authority on peritoneal surface disease. His clinical research focuses on the development of novel diagnostics and therapeutics for oligo-metastatic cancer. He is also interested in studying how big data systems can be used to provide the most optimal, cost-effective patient care.
He received his MD from the All India Institute of Medical Sciences in New Delhi. Following medical school, Turaga obtained an MPH from the Johns Hopkins Bloomberg School of Public Health. He then completed his internship and residency at Creighton University Medical Center in Omaha, followed by surgical oncology fellowships at the H. Lee Moffitt Cancer Center and Research Institute in Tampa and the University of Pittsburgh Medical Center.